The pathophysiology of pre-eclampsia: Current clinical concepts

Journal of Obstetrics and Gynaecology

Volumn 29, Issue 7, 2009, Pages 576-582

  Cudihy, D ^a   Lee, R V ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Angiogenesis; Cytokines; Endothelial cell dysfunction; Natural killer cells; Pre eclampsia; Spinal arteries

Indexed keywords

CD56 ANTIGEN; FETAL ANTIGEN;

ANGIOGENESIS; CELL INVASION; CYTOTROPHOBLAST; ENDOTHELIAL DYSFUNCTION; HEREDITY; HUMAN; IMMUNE DYSREGULATION; INNATE IMMUNITY; NATURAL KILLER CELL; PATHOGENESIS; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW;

ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; KILLER CELLS, NATURAL; NEOVASCULARIZATION, PHYSIOLOGIC; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; TROPHOBLASTS;

EID: 70350692298     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610903061751     Document Type: Review

References (44)

1. ACOG Committee on Practice Bulletins-Obstetrics. 2002. ACOG practice bulletin: Diagnosis and management of preeclampsia and eclampsia. Obstetrics and Gynecology 99:159.
2. Barton J, Sibai B. 2008. Prediction and prevention of recurrent preeclampsia. Obstetrics and Gynecology 112:359-372.
3. Chaouat G, Ledee-Bataille N, Dubanchet S. 2006. Immune cells in uteroplacental tissues throughout pregnancy: a brief review. Reproductive BioMedicine Online 14:256-266.
4. Cines D, Pollak E, Buck C, Loscalzo J, Zimmerman G, McEver R et al. 1998. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527-3561.
5. Clark J, Niles J. 1967. Abdominal pregnancy associated with toxemia of pregnancy. Journal of the National Medical Association 59:22-24.
6. Conde-Agudelo A, Villar J, Lindheimer M. 2008. Maternal infection and risk of preeclampsia: Systematic review and meta-analysis. American Journal of Obstetrics and Gynecology 198:7-22.
7. Cunningham FG, Lindheimer MD. 1992. Hypertension in pregnancy. New England Journal of Medicine 326:927-932.
8. Egleton R, Brown K, Dasgupta P. 2009. Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases. Pharmacology and Therapeutics 121:205-223.
9. Esplin M, Fausett M, Fraser A, Kerber R, Mineau G, Carrillo J et al. 2001. Paternal and maternal components of the predisposition to preeclampsia. New England Journal of Medicine 344:867.
10. Goldman-Whol D, Ariel I, Greenfield C, Hochner-Celnikier D, Cross J, Fisher S et al. 2000. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with preeclampsia. Molecular Human Reproduction 6:88-95.
11. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, 2006. Decidual cells regulate key developmental processes at the human fetal-maternal interface. Nature Medicine 12:1065-1074.
12. Harkskamp R, Zeeman G. 2007. Preeclampsia: at risk for remote cardiovascular disease. American Journal of the Medical Sciences 334:291-295.
13. Hiby S, Walker J, O'Shaughnessy K, Redman C, Carrington M, Trowsdale J et al. 2004. Combinations of Maternal KIR and Fetal HLA-C Genes Influence the Risk of Preeclampsia and Reproductive Success. Journal of Experimental Medicine 200:957-965.
14. Hiby S, Regan L, Farrell L, Carrington M, Moffett A. 2008. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Human Reproduction 23:972-976.
15. Kopcow H, Karumanchi A. 2007. Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia. Journal of Reproductive Immunology 76:23-29.
16. Kwak-Kim J, Gilman-Sachs A. 2008. Clinical implication of natural killer cells and reproduction. American Journal of Reproductive Immunology 59:388-400.
17. Le Bouteiller P, Pizzato N, Barakonyi A, Solier C. 2003. HLA-G, pre-eclampsia, immunity and vascular events. Journal of Reproductive Immunology 59:219-234.
18. LaMarca B, Gilbert J, Granger J. 2008. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension 51:982-988.
19. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP et al. for the CPEP Study Group. 2007. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. Obstetrical and Gynecological Survey 62:82-83.
20. MMWR. 1998. Maternal mortality - United States, 1982-1996.
21. Morbidity and Mortality Weekly Report 47:705-707.
22. Maynard SE, Venkatesha S, Thadhani R, Karumanchi SA. 2005. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatric Research 57:1R-7R.
23. Miko E, Szereday L, Barakonyi A, Jarkovich A, Varga P, Szekeres-Bartho J. 2008. The role of invariant NKT cells in preeclampsia. American Journal of Reproductive Immunology 60:118-126.
24. Moffet A, Hiby S. 2007. How dose the maternal immune system contribute to the development of pre-eclampsia? Placenta 28:S51-S56.
25. Mogren I, Högberg U, Winkvist A, Stenlund H. 1999. Familial occurrence of preeclampsia. Epidemiology 10:518-522.
26. Pfarrer C, Macara L, Leiser R, Kingdom J. 1999. Adaptive angiogenesis in placentas of heavy smokers. The Lancet 354:303.
27. Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H et al. 2007. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 50:137-142.
28. Redman C, Sargent I. 2005. Latest advances in understanding preeclampsia. Science 308:1592-1594.
29. Robillard P, Dekker G, Chaouat G, Hulsey T 2007. Etiology of preeclampsia: maternal vascular predisposition and couple disease - mutual exclusion or complementarity? Journal of Reproductive Immunology 76:1-7.
30. Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. 1990. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. American Journal of Obstetrics and Gynecology 163:460-465.
31. Saito S, Sakai M, Sasaki Y, Nakashima A, Shiozaki A. 2007. Inadequate tolerance induction may induce pre-eclampsia. Journal of Reproductive Immunology 76:30-39.
32. Sargent I, Borzychowski A, Redman C. 2006. Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reproductive Biomedicine Online 13:680-686.
33. Sargent L, Borychowski A, Redman C. 2007. NK Cells and preeclampsia. Journal of Reproductive Immunology 76:40-44.
34. Scholl T, Leskiw M, Chen X, Sims M, Stein T. 2005. Oxidative stress, diet, and the etiology of preeclampsia. American Journal of Clinical Nutrition 81:1390-1396.
35. Shembrey M, Noble A. 1995. An instructive case of abdominal pregnancy. The Australian and New Zealand Journal of Obstetrics and Gynaecology 35:220-221.
36. Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D et al. 1995. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. American Journal of Obstetrics and Gynecology 172:642-648.
37. Soundararajan R, Rao A. 2004. Trophoblast 'pseudo-tumorigenesis': Significance and contributory factors. Reproductive Biology and Endocrinology 2:15.
38. South Africa Every Death Counts Writing Group. 2008. Every death counts: use of mortality audit data for decision making to save the lives of mothers, babies, and children in South Africa. Lancet 371:1294-1304.
39. Thadhani R, Solomon C. 2008. Preeclampsia - a glimpse into the future? New England Journal of Medicine 359:858-860.
40. Vikse B, Irgens L, Leivestad T, Skjærven R, Iversen B. 2008. Preeclampsia and Risk of End-Stage Renal Disease. New England Journal of Medicine 359:800-809.
41. Walker J. 2000. Pre-eclampsia. Lancet 356:1260-1265.
42. Willems J. 1977. The etiology of preeclampsia. Obstetrics and Gynecology 50:495.
43. Wiessgerber T, Wolfe L, Davies G. 2004. The role of regular physical activity in preeclampsia prevention. Medicine and Science in Sports and Exercise 36:2024-2031.
44. Wolf M, Hubel C, Lam C, Sampson M, Ecker H, Ness R et al. 2004. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. Journal of Clinical Endocrinology and Metabolism 89:6239-6243.